{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:52:37Z","timestamp":1787237557520,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["4021178"],"award-info":[{"award-number":["4021178"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.micpath.2025.107927","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:18:07Z","timestamp":1753399087000},"page":"107927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Antibiotic-peptide conjugates as alternatives to conventional antibiotics for treating infections caused by hospital-associated ESKAPE pathogens: A systematic review"],"prefix":"10.1016","volume":"207","author":[{"given":"Yadollah","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Darvishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyghobad","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Chegene Lorestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Madanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-7019","authenticated-orcid":false,"given":"Mosayeb","family":"Rostamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.107927_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micpath.2025.107927_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2025.107927_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.micpath.2025.107927_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2025.107927_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107927_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/14787210.2023.2256975","article-title":"Phenotypic, genotypic, and metabolic resistance mechanisms of ESKAPE bacteria to chemical disinfectants: a systematic review and meta-analysis","volume":"21","author":"Chegene Lorestani","year":"2023","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micpath.2025.107927_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107927_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","article-title":"Antibacterial peptides for therapeutic use: obstacles and realistic outlook","volume":"6","author":"Marr","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107927_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/ph16111615","article-title":"Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review","volume":"16","author":"Muteeb","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2025.107927_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2025.107927_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100954","article-title":"Antimicrobial peptides for combating drug-resistant bacterial infections","volume":"68","author":"Xuan","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.micpath.2025.107927_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115377","article-title":"Antimicrobial peptides: structure, mechanism, and modification","volume":"255","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2025.107927_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10989-022-10477-z","article-title":"Recent patents and FDA-approved drugs based on antiviral peptides and other peptide-related antivirals","volume":"29","author":"Mousavi Maleki","year":"2022","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.micpath.2025.107927_bib14","first-page":"48","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil Med Res"},{"key":"10.1016\/j.micpath.2025.107927_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/14787210.2021.1912593","article-title":"Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2","volume":"19","author":"Mousavi Maleki","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micpath.2025.107927_bib16","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/jam.15314","article-title":"Antimicrobial peptides (AMPs): a promising class of antimicrobial compounds","volume":"132","author":"Erdem B\u00fcy\u00fckkiraz","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2025.107927_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/ijms17050701","article-title":"Design and application of antimicrobial peptide conjugates","volume":"17","author":"Reinhardt","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107927_bib18","doi-asserted-by":"crossref","DOI":"10.24272\/j.issn.2095-8137.2023.246","article-title":"Design methods for antimicrobial peptides with improved performance","author":"Mwangi","year":"2023","journal-title":"Zool. Res."},{"key":"10.1016\/j.micpath.2025.107927_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170666","article-title":"Chemical modifications to increase the therapeutic potential of antimicrobial peptides","volume":"146","author":"Han","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.micpath.2025.107927_bib20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cbdd.13930","article-title":"Antibiotic\u2013cell\u2010penetrating peptide conjugates targeting challenging drug\u2010resistant and intracellular pathogenic bacteria","volume":"98","author":"Zeiders","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.micpath.2025.107927_bib21","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2174\/1568026619666181129141524","article-title":"Antibiotics-peptide conjugates against multidrug-resistant bacterial pathogens","volume":"18","author":"David","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.micpath.2025.107927_bib22","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acsinfecdis.2c00406","article-title":"Development of antimicrobial peptide\u2013antibiotic conjugates to improve the outer membrane permeability of antibiotics against gram-negative bacteria","volume":"8","author":"Yamauchi","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107927_bib23","first-page":"445","article-title":"Antimicrobial peptides therapy: an emerging alternative for treating drug-resistant bacteria","volume":"95","author":"Mba","year":"2022","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.micpath.2025.107927_bib24","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12667","article-title":"Antimicrobial peptides properties beyond growth inhibition and bacterial killing","volume":"10","author":"Castillo-Ju\u00e1rez","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.micpath.2025.107927_bib25","doi-asserted-by":"crossref","DOI":"10.2174\/1389203722666210322145810","article-title":"Dissecting the therapeutic potency of antimicrobial peptides against microbial biofilms","volume":"22","author":"Gupta","year":"2021","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.micpath.2025.107927_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.peptides.2014.09.021","article-title":"Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides","volume":"62","author":"Dosler","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.micpath.2025.107927_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00281","article-title":"Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds","volume":"9","author":"Pfalzgraff","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107927_bib28","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.3390\/molecules27092995","article-title":"The role of antimicrobial peptides as antimicrobial and antibiofilm agents in tackling the silent pandemic of antimicrobial resistance","volume":"27","author":"Lopes","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2025.107927_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11274-020-02907-1","article-title":"Antimicrobial peptide polymers: no escape to ESKAPE pathogens\u2014a review","volume":"36","author":"Mukhopadhyay","year":"2020","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107927_bib30","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.micpath.2025.107927_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.micpath.2025.107927_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039768","article-title":"Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides","volume":"7","author":"Arnusch","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.107927_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cbpa.2017.03.014","article-title":"Host defense antimicrobial peptides as antibiotics: design and application strategies","volume":"38","author":"Mishra","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.micpath.2025.107927_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbrc.2021.02.106","article-title":"First report of antifungal activity of CecropinA-Magenin2 (CE-MA) hybrid peptide and its truncated derivatives","volume":"549","author":"Namvar Erbani","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2025.107927_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/cbdd.13689","article-title":"Design of new truncated derivatives based on direct and reverse mirror repeats of first six residues of Caerin 4 antimicrobial peptide and evaluation of their activity and cytotoxicity","volume":"96","author":"Madanchi","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.micpath.2025.107927_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105866","article-title":"Determination of antifungal activity and action mechanism of the modified Aurein 1.2 peptide derivatives","volume":"173","author":"Madanchi","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107927_bib37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12866-023-03090-7","article-title":"Investigating the antimicrobial activity, cytotoxicity, and action mechanism of acylated and amidated derivatives of AurH1 antifungal peptide","volume":"23","author":"Nikookar Golestani","year":"2023","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2025.107927_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108570","article-title":"Advances in antimicrobial peptides: from mechanistic insights to chemical modifications","volume":"81","author":"Yang","year":"2025","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.micpath.2025.107927_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1567201811666140910094050","article-title":"Levofloxacin and indolicidin for combination antimicrobial therapy","volume":"12","author":"Ghaffar","year":"2015","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.micpath.2025.107927_bib40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/molecules22060957","article-title":"Synthesis and evaluation of antimicrobial activity of [R4W4K]-Levofloxacin and [R4W4K]-Levofloxacin-Q conjugates","volume":"22","author":"Riahifard","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2025.107927_bib41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/antibiotics11030416","article-title":"Combination of amphiphilic cyclic peptide [R4W4] and levofloxacin against multidrug-resistant bacteria","volume":"11","author":"Sajid","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107927_bib42","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbamem.2015.10.018","article-title":"Molecular mechanisms of membrane targeting antibiotics","volume":"1858","author":"Epand","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.micpath.2025.107927_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12874-021-01295-w","article-title":"Quality assessment tools used in systematic reviews of in vitro studies: a systematic review","volume":"21","author":"Tran","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.micpath.2025.107927_bib44","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1128\/AAC.49.3.1184-1189.2005","article-title":"A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis","volume":"49","author":"Qiu","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107927_bib45","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1021\/acs.molpharmaceut.5b00053","article-title":"Bacteria-targeting conjugates based on antimicrobial peptide for bacteria diagnosis and therapy","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2025.107927_bib46","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1021\/acschembio.7b00540","article-title":"Enhancing the potency of nalidixic acid toward a bacterial DNA gyrase with conjugated peptides","volume":"12","author":"Ahmed","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.micpath.2025.107927_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/acs.bioconjchem.6b00725","article-title":"Designing hybrid antibiotic peptide conjugates to cross bacterial membranes","volume":"28","author":"Deshayes","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.micpath.2025.107927_bib48","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbagen.2017.01.029","article-title":"Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate","volume":"1861","author":"Mohamed","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.micpath.2025.107927_bib49","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1021\/jacs.8b08711","article-title":"A dual-function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells","volume":"140","author":"Antonoplis","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.micpath.2025.107927_bib50","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2147\/IDR.S160975","article-title":"Novel vancomycin\u2013peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus","volume":"11","author":"Jelinkova","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2025.107927_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24059","article-title":"Covalent conjugation of cationic antimicrobial peptides with a \u03b2\u2010lactam antibiotic core","volume":"110","author":"Li","year":"2018","journal-title":"Pept Sci"},{"key":"10.1016\/j.micpath.2025.107927_bib52","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/s41598-019-40103-w","article-title":"Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin","volume":"9","author":"Ruczy\u0144ski","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107927_bib53","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1021\/acscentsci.0c00893","article-title":"\u201cMetaphilic\u201d cell-penetrating polypeptide-vancomycin conjugate efficiently eradicates intracellular bacteria via a dual mechanism","volume":"6","author":"Jiang","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.micpath.2025.107927_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3277","article-title":"Antimicrobial therapeutic enhancement of levofloxacin via conjugation to a cell\u2010penetrating peptide: an efficient sonochemical catalytic process","volume":"26","author":"Taheri\u2010Ledari","year":"2020","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.micpath.2025.107927_bib55","doi-asserted-by":"crossref","first-page":"16854","DOI":"10.1021\/acs.jmedchem.1c01712","article-title":"Multifunctional antibiotic\u2013host defense peptide conjugate kills bacteria, eradicates biofilms, and modulates the innate immune response","volume":"64","author":"Etayash","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:53:43Z","timestamp":1772772823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025006527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S0882401025006527"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107927","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic-peptide conjugates as alternatives to conventional antibiotics for treating infections caused by hospital-associated ESKAPE pathogens: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107927"}}